Statins such as atorvastatin (Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor) are among the widely used prescription drugs.
Since the drugs were first marketed 30 years ago in the U.S. for preventing a second heart attack or stroke in those who’ve already had one, there’s been a shift toward prescribing statins for otherwise healthy people in Canada and the U.S.
“These are patients who really haven’t had an event, a cardiovascular event, but they seem to be at high risk,” said pharmacy Prof. Muhammad Mamdani, who works at St. Michael’s Hospital in Toronto.
“You also get populations where people seem to be relatively healthy, their cholesterol levels aren’t that high, but for whatever reason, they are placed on a statin. That’s a patient population that is a lot more debatable and some practices may not be warranted.”
- Statins could lead to muscular injuries, scientists warn (telegraph.co.uk)